All data are based on the daily closing price as of March 28, 2025
g
GemVax&KAEL
082270.KQ
23.72 USD
-0.62
-2.55%
Overview
Last close
23.72 usd
Market cap
846.07M usd
52 week high
28.65 usd
52 week low
7.31 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
21.9409
Price/Book Value
18.4209
Enterprise Value
956.48M usd
EV/Revenue
22.4114
EV/EBITDA
-173.0774
Key financials
Revenue TTM
53.67M usd
Gross Profit TTM
12.70M usd
EBITDA TTM
1.57M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
109.35M usd
Net debt
N/A usd
About
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.